Resp Med News Today

Renowned medical experts at the American Thoracic Society International Conference unveiled new evidence that demonstrates treating obstructive sleep apnea (OSA) with positive airway pressure (PAP) therapy lowers all-cause mortality for patients

France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with... | May 25, 2023

(2023-05-25 | NYSE:RMD) 3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023

2-3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 yearsHealth benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE)

ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day GlobeNewswire March 14, 2022 Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at nightQuality and quantity of sleep have benefitted from...

Threefold to sixfold higher hospitalization risk depending on definition

email article Hospitalized COVID-19 patients may safely continue taking their angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the small REPLACE COVID trial. The studys primary hierarchical endpoint -- a global rank score in which patients were ranked by the severity of their COVID disease course according to various biomarkers and clinical events, with a lower rank score meaning more severe COVID-19 hospitalization -- was about the...